Medpace Holdings (NASDAQ: MEDP) reported Q4 EPS of $1.32, $0.07 better than the analyst estimate of $1.25. Revenue for the quarter came in at $308.6 million versus the consensus estimate of $309.04 million.

GUIDANCE:

Medpace Holdings sees FY2022 EPS of $5.35-$5.67, versus the consensus of $5.49. Medpace Holdings sees FY2022 revenue of $1.4-1.46 billion, versus the consensus of $1.44 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.